FDA to phase out dyes used in Flamin’ Hot Cheetos, Skittles and other snacks

FDA to phase out dyes used in Flamin’ Hot Cheetos, Skittles and other snacks

Candy is displayed for sale, as U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., along with FDA Commissioner Marty Makary, announce the FDA’s intent to remove from the U.S. food supply “petroleum-based synthetic” food dyes, which are present in numerous foods such as breakfast cereals, candy, snacks, and beverages, at a grocery … Read more

Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma

Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma

U.S. President Donald Trump speaks to the media during the annual White House Easter Egg Roll, on the South Lawn of the White House in Washington, D.C., U.S., April 21, 2025. Leah Millis | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to … Read more

UnitedHealth’s stock is plunging on higher medical costs. That may mean trouble for more insurers

UnitedHealth’s stock is plunging on higher medical costs. That may mean trouble for more insurers

The logo of UnitedHealth appears on the side of one of its office buildings in Santa Ana, California, on April 13, 2020. Mike Blake | Reuters UnitedHealth Group‘s stock sank 20% on Thursday after the company slashed its annual profit forecast, citing higher-than-expected medical costs in its privately run Medicare plans.  Those bleak results from … Read more

Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients

Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients

Eli Lilly on Thursday said its daily obesity pill met the company’s goals in the first of several late-stage trials, helping patients with Type 2 diabetes lower their blood sugar and body weight and showing safety comparable with popular injections on the market.  The trial results are among the pharmaceutical industry’s most closely watched studies … Read more

Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs

Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs

A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024.  Nurphoto | Nurphoto | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to … Read more

Pfizer scraps daily weight loss pill after liver injury in one patient

Pfizer scraps daily weight loss pill after liver injury in one patient

Kena Betancur | Corbis News | Getty Images Pfizer on Monday said it would end development of its experimental daily weight loss pill after a patient experienced a liver injury that was potentially caused by the drug in a trial.  The patient did not experience any liver-related symptoms or side effects, a Pfizer spokesperson said … Read more

Trump’s pharmaceutical tariffs could raise costs for patients, worsen drug shortages

Trump’s pharmaceutical tariffs could raise costs for patients, worsen drug shortages

A pharmacist collects medications for prescriptions at a pharmacy. Simon Dawson | Bloomberg | Getty Images President Donald Trump’s planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences for drugmakers and American patients, some experts told CNBC.  The duties could disrupt the complex pharmaceutical supply chain, drive up the prices of drugs … Read more

Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly’

Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly’

U.S. President Donald Trump speaks, on the day he signs energy-related executive orders at the White House in Washington, D.C., U.S., April 8, 2025.  Leah Millis | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future … Read more

Pharmaceutical stocks fall as Trump doubles down on tariffs threat

Pharmaceutical stocks fall as Trump doubles down on tariffs threat

The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Shares of drugmakers fell on Wednesday after President Donald Trump doubled down on plans to impose tariffs on pharmaceuticals imported into the U.S.  Shares of U.S.-based companies Eli Lilly, AbbVie, Bristol Myers Squibb and Regeneron all fell about 4% … Read more

FDA guts division that trains staff and health-care professionals on key practices like opioid safety, avoiding drug errors

FDA guts division that trains staff and health-care professionals on key practices like opioid safety, avoiding drug errors

The Food and Drug Administration has gutted a division responsible for training agency staff and outside health-care professionals on an array of key public health, regulation and safety practices and supporting professional development for employees, CNBC has learned.  In an email viewed by CNBC, workers were notified that the Division of Learning and Organizational Development, … Read more